Patents by Inventor Christopher David Reeve

Christopher David Reeve has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7888083
    Abstract: A process is provided for the preparation of a compound of formula (1) wherein R and R? represent optionally substituted hydrocarbyl groups and X represents a hydrocarbyl linking group. The process comprises either the stereoselective reduction of the keto group in a dihydroxy keto precursor followed by selective esterification of a primary hydroxy, or selective esterification of a primary hydroxy of a dihydroxy keto precursor followed by stereoselective reduction of the keto group.
    Type: Grant
    Filed: April 27, 2010
    Date of Patent: February 15, 2011
    Assignee: AstraZeneca UK Limited
    Inventors: Andrew John Blacker, Christopher David Reeve, Robert Antony Holt
  • Publication number: 20100209984
    Abstract: A process is provided for the preparation of a compound of formula (1) wherein R and R? represent optionally substituted hydrocarbyl groups and X represents a hydrocarbyl linking group. The process comprises either the stereoselective reduction of the keto group in a dihydroxy keto precursor followed by selective esterification of a primary hydroxy, or selective esterification of a primary hydroxy of a dihydroxy keto precursor followed by stereoselective reduction of the keto group.
    Type: Application
    Filed: April 27, 2010
    Publication date: August 19, 2010
    Applicant: AstraZeneca UK Limited
    Inventors: Andrew John BLACKER, Christopher David REEVE, Robert Anthony HOLT
  • Patent number: 7732171
    Abstract: A process is provided for the preparation of a compound of formula (1) wherein R and R? represent optionally substituted hydrocarbyl groups and X represents a hydrocarbyl linking group. The process comprises either the stereoselective reduction of the keto group in a dihydroxy keto precursor followed by selective esterification of a primary hydroxy, or selective esterification of a primary hydroxy of a dihydroxy keto precursor followed by stereoselective reduction of the keto group.
    Type: Grant
    Filed: July 23, 2008
    Date of Patent: June 8, 2010
    Assignee: AstraZeneca UK Limited
    Inventors: Andrew John Blacker, Christopher David Reeve, Robert Antony Holt
  • Publication number: 20080280336
    Abstract: A process is provided for the preparation of a compound of formula (1) wherein R and R? represent optionally substituted hydrocarbyl groups and X represents a hydrocarbyl linking group. The process comprises either the stereoselective reduction of the keto group in a dihydroxy keto precursor followed by selective esterification of a primary hydroxy, or selective esterification of a primary hydroxy of a dihydroxy keto precursor followed by stereoselective reduction of the keto group.
    Type: Application
    Filed: July 23, 2008
    Publication date: November 13, 2008
    Applicant: ASTRAZENECA UK LIMITED
    Inventors: Andrew John Blacker, Christopher David Reeve, Robert Anthony Holt
  • Patent number: 7416865
    Abstract: A process is provided for the preparation of a compound of formula (1) wherein R and R? represent optionally substituted hydrocarbyl groups and X represents a hydrocarbyl linking group. The process comprises either the stereoselective reduction of the keto group in a dihydroxy keto precursor followed by selective esterification of a primary hydroxy, or selective esterification of a primary hydroxy of a dihydroxy keto precursor followed by stereoselective reduction of the keto group.
    Type: Grant
    Filed: April 27, 2006
    Date of Patent: August 26, 2008
    Assignee: AstraZeneca UK Limited
    Inventors: Andrew John Blacker, Christopher David Reeve, Robert Antony Holt
  • Patent number: 7157255
    Abstract: A process is provided for the preparation of a compound of formula (1) wherein R and R? represent optionally substituted hydrocarbyl groups and X represents a hydrocarbyl linking group. The process comprises either the stereoselective reduction of the keto group in a dihydroxy keto precursor followed by selective esterification of a primary hydroxy, or selective esterification of a primary hydroxy of a dihydroxy keto precursor followed by stereoselective reduction of the keto group.
    Type: Grant
    Filed: May 1, 2001
    Date of Patent: January 2, 2007
    Assignee: AstraZeneca UK Limited
    Inventors: Andrew John Blacker, Christopher David Reeve, Robert Antony Holt
  • Patent number: 6752951
    Abstract: The present invention relates (with reference to FIG. 1a) to a method of manufacture of an integrated camera and illumination device. The method comprises assembling together an optical sensor (12), illumination means (17) and associated electronic circuitry (10) into an assembled unit; placing the assembled unit into a mold; introducing an encapsulant in liquid state into the mold to surround the components therein; and the encapsulant solidifying to form an encapsulated assembly of optical sensor, illumination means and associated electronic circuitry.
    Type: Grant
    Filed: August 7, 2002
    Date of Patent: June 22, 2004
    Assignee: Radiodetection Limited
    Inventors: Timothy Meek, Christopher David Reeve
  • Patent number: 6741286
    Abstract: The present invention (with reference to FIG. 2a) relates to an integrated camera and illumination device. The device comprises illumination apparatus having a plurality of light emitting diodes (17) arranged in a circuit which regulates current output by the circuit to an approximately constant level. The device comprises camera apparatus having a CMOS sensor (12) in a circuit supplied by the current regulated by the illumination apparatus.
    Type: Grant
    Filed: August 7, 2002
    Date of Patent: May 25, 2004
    Assignee: Radiodetection Limited
    Inventors: Timothy Meek, Christopher David Reeve
  • Publication number: 20030134900
    Abstract: A process is provided for the preparation of a compound of formula (1) 1
    Type: Application
    Filed: November 1, 2002
    Publication date: July 17, 2003
    Inventors: Andrew John Blacker, Christopher David Reeve, Robert Antony Holt
  • Publication number: 20030030180
    Abstract: The present invention relates (with reference to FIG. 1a) to a method of manufacture of an integrated camera and illumination device. The method comprises assembling together an optical sensor (12), illumination means (17) and associated electronic circuitry (10) into an assembled unit; placing the assembled unit into a mold; introducing an encapsulant in liquid state into the mold to surround the components therein; and the encapsulant solidifying to form an encapsulated assembly of optical sensor, illumination means and associated electronic circuitry.
    Type: Application
    Filed: August 7, 2002
    Publication date: February 13, 2003
    Inventors: Timothy Meek, Christopher David Reeve
  • Publication number: 20030030745
    Abstract: The present invention (with reference to FIG. 2a) relates to an integrated camera and illumination device. The device comprises illumination apparatus having a plurality of light emitting diodes (17) arranged in a circuit which regulates current output by the circuit to an approximately constant level. The device comprises camera apparatus having a CMOS sensor (12) in a circuit supplied by the current regulated by the illumination apparatus.
    Type: Application
    Filed: August 7, 2002
    Publication date: February 13, 2003
    Inventors: Timothy Meek, Christopher David Reeve
  • Patent number: 6335187
    Abstract: Chiral amines are resolved by selectively reacting an enantiomer of the amine with an alkyl ester in the presence of an enantioselective lipase enzyme to produce an amide of that enantiomer and separating it from the unreacted enantiomer, the alkyl group of the ester being an isoalkyl group. Isobutyl and especially isopropyl groups are preferred.
    Type: Grant
    Filed: June 6, 2000
    Date of Patent: January 1, 2002
    Assignee: Avecia Limited
    Inventor: Christopher David Reeve
  • Patent number: 6001615
    Abstract: A compound of formula (III) ##STR1## is produced by selectively reducing a compound of formula (II) ##STR2## using a reductase possessing the properties of one produced by Beauveria, Candida, Kluyveromyces, Torulaspora or Pichia.orA compound of formula ##STR3## is produced by selectively reducing a compound of formula II using a reductase possessing the properties of one produced by Candida pelliculosa, Neurospora crassa, Pichia trehalophila or preferably Hansenula anomola.
    Type: Grant
    Filed: December 23, 1997
    Date of Patent: December 14, 1999
    Assignee: Zeneca Limited
    Inventor: Christopher David Reeve